Overview

Endometriosis: Immunomodulation

Status:
Withdrawn

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the effect of pioglitazone versus no drug on soluble profinflammatory markers in peritoneal fluid of women with endometriosis.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

University of Wisconsin, Madison

Treatments:

Pioglitazone